You have several strong MS care options across Washington, from Seattle's academic centers to regional systems in the Puget Sound area. Consider factors like center size, pediatric versus adult focus, and location when comparing EvergreenHealth, Swedish Neuroscience Institute, UW Medicine, Virginia Mason, and Seattle Children's to find the right fit for your needs.
10 MS treatment centers0 Active clinical trialsIncludes major academic and pediatric programs2 providers with Medicare prescribing data
Center types in Washington
Community Hospital Program (4)
Dedicated MS Practice (3)
Academic MS Center (2)
Regional Neurology Group (1)
Filter by type:All (10)Community Hospital Program (4)Dedicated MS Practice (3)Academic MS Center (2)Regional Neurology Group (1)
40% of MS centers in Washington are classified as Community Hospital Program facilities.
Centers with Most Active Trials in Washington
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
Largest Care Teams in Washington
2. UW Medicine Multiple Sclerosis Center1 provider
MS Care by City
Seattle4
Spokane2
Tacoma2
Kirkland1
Richland1
Compare MS Centers in Washington
| Center | Type | Infusion | Virtual | Experience |
|---|---|---|---|---|
| Dedicated MS Practice | — | ✓ | 3.8/5 | |
| Academic MS Center | ✓ | ✓ | 3.4/5 | |
Holy Family MS Center Spokane | Community Hospital Program | — | — | 2.4/5 |
Kadlec Neuroscience Center Richland | Regional Neurology Group | — | — | 2.4/5 |
| Community Hospital Program | — | — | 2.4/5 | |
| Community Hospital Program | — | — | 3/5 | |
| Community Hospital Program | — | — | 2.6/5 | |
| Academic MS Center | ✓ | ✓ | 3.6/5 | |
| Dedicated MS Practice | — | — | 3/5 | |
| Dedicated MS Practice | ✓ | ✓ | 3.8/5 |
EvergreenHealth Multiple Sclerosis Center
Kirkland • Dedicated MS Practice
Infusion
—
Virtual
✓
Experience
3.8/5
UW Medicine Multiple Sclerosis Center
Seattle • Academic MS Center
Infusion
✓
Virtual
✓
Experience
3.4/5
Holy Family MS Center
Spokane • Community Hospital Program
Infusion
—
Virtual
—
Experience
2.4/5
Kadlec Neuroscience Center
Richland • Regional Neurology Group
Infusion
—
Virtual
—
Experience
2.4/5
MultiCare Tacoma General Hospital
Tacoma • Community Hospital Program
Infusion
—
Virtual
—
Experience
2.4/5
Neurology and Neurosurgery Associates of Tacoma, Inc., P.S.
Tacoma • Community Hospital Program
Infusion
—
Virtual
—
Experience
3/5
Providence Multiple Sclerosis Center
Spokane • Community Hospital Program
Infusion
—
Virtual
—
Experience
2.6/5
Seattle Children's Hospital Neuroimmunology Program
Seattle • Academic MS Center
Infusion
✓
Virtual
✓
Experience
3.6/5
Swedish Neuroscience Institute MS Center
Seattle • Dedicated MS Practice
Infusion
—
Virtual
—
Experience
3/5
Virginia Mason Multiple Sclerosis Center
Seattle • Dedicated MS Practice
Infusion
✓
Virtual
✓
Experience
3.8/5
Active MS clinical trials in Washington
See all 28 trials →ActivePhase 4
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
Kirkland · Seattle
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Seattle · Seattle
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Kirkland · Seattle
ActivePhase 3
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Seattle · Tacoma
ActivePhase 3
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
Kirkland · Tacoma
ActivePhase 2
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
Fred Hutchinson Cancer Center
Seattle · Seattle
ActivePhase 3
An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
TG Therapeutics, Inc.
Seattle
ActivePhase 3
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Kirkland
Check out the MS Buddy App
It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
